Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston toremifene citrate is FDA-approved for use in advanced (metastatic) breast cancer.
This page contains content from the copyrighted Wikipedia article "Toremifene"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
